Euroapi Investor Relations Material
Latest events
H1 2024
Euroapi
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Euroapi S.A.
Access all reports
Euroapi S.A., operating under the brand EUROAPI, is a global leader in the production of active pharmaceutical ingredients (APIs). The company boasts an extensive portfolio of over 200 products, serving the healthcare industry by developing, manufacturing, and distributing APIs and intermediates. These ingredients are crucial for the formulation of medicines intended for both human and veterinary use, catering to a broad spectrum of therapeutic areas including small molecules, lipids, microbial fermentation, and more. EUROAPI's offerings also encompass Contract Development and Manufacturing Organization (CDMO) services. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris stock exchange.
Key slides for Euroapi S.A.
Investor Update
Euroapi S.A.
H1 2024
Euroapi S.A.
Latest articles
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
Ticker symbol
EAPI
Country
🇫🇷 France